Clinical Trial

Quantitative Xylazine Measurement in ED

Name: Quantitative Xylazine Measurement in ED — clinical trial record (NCT06949605)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-04-22; most recent amendment 2026-03-24.

Status change: Recruiting → Completed 2026-03-24

Status change: Not Yet Recruiting → Recruiting 2025-05-19

Trial Details

NCT Number	NCT06949605
Lead Sponsor	Icahn School of Medicine at Mount Sinai Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Opioid Overdose, Substance Use Disorders
Enrollment	75 participants
Start Date	2025-04-01
Primary Completion	2026-02-28 (estimated)
Study Completion	2026-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-03-25